Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sustainable Upscaling of Depression Prevention, Finding the Optimal Balance Between Investment and Benefit (SPRINT)

NCT05633186 is registered in ClinicalTrials.gov with VU University of Amsterdam as lead sponsor.

NCT NCT05633186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05633186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sustainable Upscaling of Depression Prevention, Finding the Optimal Balance Between Investment and Benefit (SPRINT)
Lead sponsor
VU University of Amsterdam
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2022
Completion date
March 31, 2023
Enrollment
307 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression